Pheochromocytomas/paragangliomas are characterized by a unique molecular landscape
that allows their assignment to clusters based on underlying genetic alterations. With around …

A molecular biology–based taxonomy has been proposed for pheochromocytoma and
paraganglioma (PPGL). Data from the Cancer Genome Atlas revealed clinically relevant …

Objective: The aim was to formulate clinical practice guidelines for pheochromocytoma and
paraganglioma (PPGL). Participants: The Task Force included a chair selected by the …

Paragangliomas are neuroendocrine tumors frequently associated with mutations in RET,
NF1, VHL, and succinate dehydrogenase (SDHx) genes. Methylome analysis of a large …

Phaeochromocytomas are rare neuroendocrine tumours with a highly variable clinical
presentation but most commonly presenting with episodes of headaches, sweating …

This volume covers tumors of the pituary, the thyroid and parathyroid, the adrenal gland, the
endocrine pancreas, and inherited tumor syndromes. Each entity is extensively discussed …

Clinically inapparent adrenal masses are incidentally detected after imaging studies
conducted for reasons other than the evaluation of the adrenal glands. They have frequently …

Phaeochromocytomas and paragangliomas (PPGLs) release catecholamines leading to
catecholamine-induced hypertensive (CIH) crises, with blood pressure greater than or equal …

Pheochromocytomas are rare neuroendocrine tumors with a highly variable clinical
presentation, but they most commonly present as spells of headaches, sweating …

Context: Besides 123I-metaiodobenzylguanidine (MIBG), positron emission tomography
(PET) agents are available for the localization of paraganglioma (PGL), including 18F-3, 4 …